DRUG · Unmapped registry intervention
TT-00420
Find medicine records ·
Find other trials using this name
Clinical trial
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
NCT04742959
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
COMBINATION_PRODUCT · Unmapped registry intervention
Nab-Paclitaxel
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Solid Tumorunresolved
Cholangiocarcinomaverified · MONDO: cholangiocarcinoma
HER2-negative Breast Cancerunresolved
Bladder Cancerunresolved
Prostate Cancerverified · MONDO: prostate cancer
Thyroid Cancerverified · MONDO: thyroid cancer
Sarcomaverified · MONDO: sarcoma
Gastric Cancerverified · MONDO: gastric cancer
Gallbladder Cancerverified · MONDO: gallbladder cancer
Interventions
TT-00420DRUG
Nab-PaclitaxelCOMBINATION_PRODUCT
Sponsors & collaborators
TransThera Sciences (Nanjing), Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04742959 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.